Physician profile
Kinsman E Wright
NPI 1598764706
$5,851.44
in general payments reported to CMS, 2019-2025
43 companies · $1,119 in 2025
The $1,119 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,101 · 2020: $590 · 2021: $262 · 2022: $614 · 2023: $966 · 2024: $1,200 · 2025: $1,119.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,285.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,284.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $1,420.51 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $569.55 | 2019-2024 | Xarelto |
| Pfizer INC. | $485.06 | 2022-2025 | |
| E.R. Squibb & Sons, L.L.C. | $373.92 | 2019-2025 | Camzyos, Eliquis |
| Amgen INC. | $352.31 | 2019-2025 | Repatha, Repatha |
| Medtronic, INC. | $312.04 | 2022-2025 | Aurora Ev-Icd Mri Surescan, Pulseselect |
| Astellas Pharma US INC | $237.15 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $200.61 | 2021-2025 | Jardiance |
| Boston Scientific Corporation | $170.91 | 2019-2025 | Watchman Flx |
| Philips North America LLC | $159.60 | 2022-2025 | (Ck4) Mcot, Ambulatory Monitoring & Diagnostics Undivided |
| Merck Sharp & Dohme LLC | $122.57 | 2022-2024 | Verquvo |
| Astrazeneca Pharmaceuticals Lp | $116.67 | 2019-2025 | Farxiga, Wainua |
| Scpharmaceuticals INC. | $91.37 | 2024-2025 | |
| Sanofi-Aventis U.S. LLC | $79.98 | 2020-2024 | |
| Alnylam Pharmaceuticals INC. | $79.69 | 2019-2022 |
Show all 43 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kinsman Wright listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.